Saturday 17 October 2026 Export MDCX’s income statement to Excel — free account

Medicus Pharma Ltd

MDCX Healthcare Drug Manufacturers General

In the quarter to June 2026, EPS grew 51.2% and free cash flow fell 27.7%, each against the same quarter a year earlier.

3.27 0.16 −4.66%

Follow MDCX

Alert me

Market cap: $6.3M
P/E: 0.0×
Fwd P/E: —
Dividend yield: —
F-score: n/a
Altman Z: n/a
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	(2,660.03%)	(2,981.87%)	(2,877.17%)	(7,441.07%)
ROA Full definition →		(455.33%)	(602.13%)	(786.20%)	(290.34%)
ROIC Full definition →		0.00%	0.00%	0.00%	(2,497.51%)
Return on Tangible Assets Full definition →		4,077.59%	99,562.95%	(3,870.91%)	(923.27%)
Free Cash Flow per Share Full definition →		(1.04)	(1.32)	(0.94)	(0.53)
Free Cash Flow Full definition →		(19.36)	(22.78)	(27.81)	(29.32)
Other line items
Cash ROIC Full definition →		(246.39%)	(260.53%)	(356.78%)	(93.28%)
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Operating CF/Net income Full definition →		0.54	0.48	0.54	0.52
Revenue per Share Full definition →		0.00	0.00	0.00	0.00
Operating CF per Share Full definition →		(1.04)	(1.32)	(0.94)	(0.53)
Capex per Share Full definition →		0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates